Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade
The consensus price target hints at a 124.6% upside potential for Vor Biopharma (VOR). While empiric…
zacks.com
BCRH(BCRH)
BCRH
+0.00%(+0.00)
Prev Close
6.72
Day High
6.72
Day Low
6.72
Avg Volume
62,371
52W High
9.11
52W Low
6.05
Signal
Bullish Setup1↑
PRICE
Prev Close
6.72
Open
—
Day Range—
52W Range6.05 – 9.11
6.05
9.11
22% of range
VOLUME & SIZE
Avg Volume
62.4K
FUNDAMENTALS
P/E Ratio
-2.5x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev -27% · 100% gross marginValuation
FAIR
P/E not availableHealth
MODERATE
CR 0.2 (low) · FCF $0.01/shLean Bullish
Key MetricsTTM
Market Cap$58.97M
Revenue TTM$33.40M
Net Income TTM-$28.60M
Free Cash Flow$100.0K
Gross Margin100.0%
Net Margin-85.6%
Operating Margin-85.6%
Return on Equity-26.3%
Return on Assets-17.5%
Debt / Equity0.04
Current Ratio0.16
EPS TTM$-3.26
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
1 strong5 concern
18/100Liquidity
0.16Concern
Leverage
0.04Strong
Coverage
0.0xConcern
ROE
-26.3%Concern
ROIC
-30.2%Concern
Cash
$2MConcern
ANALYST COVERAGE1 analysts
HOLD
Stock Health
Composite Score
0 of 3 signals bullish
3/10
Technicals
●
~RSI RangeRSI 0 — Oversold, watch for bounce
Fundamentals
●
~Analyst ConsensusHold
●
✗LiquidityCurrent Ratio 0.16 — liquidity risk
2 signals unavailable — limited data for this stock
Upcoming Events
EEarnings ReportMay 8, 2026
Tomorrow
DEx-Dividend DateAug 5, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 105 days
FinancialsFull statements →
Technicals
Technical SetupMIXED
Technicals →Trend
▼ DowntrendDeath Cross · 50D trails 200D by 0.9%
-2.7% vs SMA 50 · -3.6% vs SMA 200
Momentum
RSI0.0Oversold — potential bounce
Market Position
Price Levels
52W High
$9.11+35.6%
EMA 50
$6.85+2.0%
Current
$6.72
52W Low
$6.05-10.0%
52-Week RangeNear 52-week low
$6.0522th %ile$9.11
Earnings & Analysts
Financials
News & Activity
BCRH News
20 articles · 4h ago
Does Atlassian (TEAM) Have the Potential to Rally 41.53% as Wall Street Analysts Expect?
zacks.com
OFG Bancorp (OFG)'s Technical Outlook is Bright After Key Golden Cross
zacks.com
Wall Street Analysts Believe Lifezone Metals Limited (LZM) Could Rally 60.32%: Here's is How to Trade
zacks.com
How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%
zacks.com
After Golden Cross, UMB Financial (UMBF)'s Technical Outlook is Bright
zacks.com
Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade
zacks.com
Wall Street Analysts Think JBT (JBTM) Could Surge 31.85%: Read This Before Placing a Bet
zacks.com
Does DAVE INC (DAVE) Have the Potential to Rally 30.52% as Wall Street Analysts Expect?
zacks.com
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?
zacks.com
West Pharmaceutical Services (WST) Just Flashed Golden Cross Signal: Do You Buy?
zacks.com
Investors Should Dump Snap Stock As Fast As They Can
247wallst.com
Everything you eat at The Cheesecake Factory is made in-house, except for its most iconic dish
businessinsider.com
ESAB Corporation (ESAB) Q1 2026 Earnings Call Transcript
seekingalpha.com
Paycom's Q1 Earnings Surpass Expectations, Revenues Rise Y/Y
zacks.com
Why Anheuser-Busch Inbev (BUD) is a Top Momentum Stock for the Long-Term
zacks.com
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
zacks.com
Why Ameriprise Financial Services (AMP) is a Top Momentum Stock for the Long-Term
zacks.com
Why HSBC (HSBC) is a Top Momentum Stock for the Long-Term
zacks.com
Here's Why Omnicell (OMCL) is a Strong Momentum Stock
zacks.com
About
Blue Capital Reinsurance Holdings Ltd. is a reinsurance holding company, which engages in the provision of collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. It operates through its wholly-owned subsidiaries: Blue Capital Re Ltd and Blue Capital Re ILS Ltd. The company was founded on June 24, 2013 and is headquartered in Pembroke, Bermuda.